Season 6, Episode 15 - What‘s hot in viral hepatitis in 2024?

This session will cover a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk will provide you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.

Faculty: Thomas Berg (Moderator), Jordan Feld (Faculty), Norah Terrault (Faculty), Heiner Wedemeyer (Faculty)

This episode is scheduled in honour of the United States’ Viral Hepatitis Awareness Month.

Related episodes:

• Season 6, Episode 2: Why do we need HBV functional cure?
• Season 5, Episode 8: JHEP Live: Hepatitis Delta’s Latest Debate: Updates Straight from EASL’s Slate
• Season 5, Episode 3: Zoonotic Hepatitis E: What’s hot in 2023?
• EASL Studio at the EASL Congress 2023: The bumpy road of Hepatitis B drug development successes and challenges
• Season 4, Episode 19: HDV: The devil becomes treatable
• Season 4, Episode 1: Hepatitis B elimination: how far behind are we and what do we need to change to achieve it?